Capture | Detect | Discover
Mabtech is a Swedish biotech company founded in 1986. Our mission is to aid researchers to reach new frontiers and develop novel therapies, by supplying optimal immunoassays based on high-quality monoclonal antibodies and instruments.
We develop and produce a wide range of monoclonal antibodies to cytokines and immunoglobulins. By selecting optimal matching pairs of capture and detection antibodies, we develop dependable sandwich assays such as ELISA, ELISpot and FluoroSpot kits. These kits are used to study immune responses in e.g. infectious disease, cancer, allergy, transplantation and as monitoring tools in vaccine trials.
Our readers deliver unbiased spot analysis by combining an innovative algorithm with state-of-the-art hardware. Mabtech IRIS is our next-generation 4-color FluoroSpot/ELISpot reader enabling reliable multiplexing. Mabtech ASTOR is a reader with the same innovative and user-friendly technology for labs performing only ELISpot.
Research can be challenging. We love to support your quest for answers. Please contact us, by phone, via e-mail, social media or in our forum, and we will do our best to assist you.
Location: Sweden, Nacka
Employees: 11-50
Founded date: 1986
Investors 1
Date | Name | Website |
- | Merieux De... | merieux-pa... |
Mentions in press and media 1
Date | Title | Description | Source |
09.01.2024 | EQT introduces the EQT Healthcare Growth Strategy, a dedicat... | EQT introduces the EQT Healthcare Growth Strategy, a dedicated healthcare buyout strategy, with the ... | news.cisio... |